GlassScriptPhysician profile
Tamara L Fehr
NPI 1982030896
$6,015.18
in general payments reported to CMS, 2019-2025
28 companies · $3,119 in 2025
The $3,119 reported for 2025 was more than what 97% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $313 · 2022: $1,513 · 2023: $544 · 2024: $526 · 2025: $3,119.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,370 · Travel and Lodging: $756 · Education: $61.95.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,370.49 |
| Travel and Lodging | $756.23 |
| Education | $61.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $1,741.76 | 2021-2024 | Axonics |
| Boston Scientific Corporation | $1,125.87 | 2025 | Ams 700 Cxr Rte Kit, Ams 700, Axonics |
| Astellas Pharma US INC | $502.80 | 2021-2025 | Xtandi, Myrbetriq |
| Bayer Healthcare Pharmaceuticals INC. | $394.51 | 2022-2025 | |
| Abbvie INC. | $245.21 | 2022-2025 | |
| Procept Biorobotics Corporation | $221.33 | 2023-2025 | Aquabeam Robotic System |
| Coloplast Corp | $188.53 | 2022-2025 | Speedicath |
| Sumitomo Pharma America, INC. | $176.65 | 2023-2025 | Gemtesa, Orgovyx |
| Srs Medical Systems, INC. | $167.29 | 2025 | Ct3000 Pro Base Unit, Urocuff-Dc Disposable, Single |
| Ferring Pharmaceuticals INC. | $160.24 | 2025 | Adstiladrin |
| Tolmar, INC. | $151.85 | 2025 | Jatenzo, Eligard |
| Endo USA, INC. | $149.39 | 2024-2025 | Xiaflex, Aveed, Edex |
| Novartis Pharmaceuticals Corporation | $105.26 | 2025 | |
| Urogen Pharma, INC. | $82.84 | 2025 | |
| Allergan, INC. | $81.11 | 2021-2022 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dendreon Pharmaceuticals LLC | $78.92 | 2025 | Provenge |
| Bluewind Medical | $73.02 | 2025 | |
| Pfizer INC. | $63.50 | 2021-2023 | |
| Urovant Sciences INC | $60.28 | 2022 | |
| Laborie Medical Technologies Corp. | $53.25 | 2023-2025 | Aquarius Lt |
| Teleflex LLC | $48.75 | 2025 | Urolift, Barrigel |
| Astrazeneca Pharmaceuticals LP | $32.06 | 2025 | Lynparza |
| Verity Pharmaceuticals INC. | $22.10 | 2025 | Trelstar |
| Blue Earth Diagnostics | $22.09 | 2024 | |
| Endo Pharmaceuticals INC. | $19.33 | 2022 | |
| Becton, Dickinson and Company | $17.00 | 2025 | Bard Urinary Drainage Bag |
| Kowa Pharmaceuticals America, INC. | $16.60 | 2023 | Seglentis |
| Janssen Biotech, INC. | $13.64 | 2025 | Erleada |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tamara Fehr listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.